Aurinia Pharmaceuticals (AUPH) Proxy Filing summary

Executive summary

• ISS recommended voting in favor of all proposals at the 2025 Annual General Meeting, supporting the Board's slate and agenda.

• The meeting is scheduled for May 15, 2025, with a record date of April 12, 2025, for shareholder eligibility.

• Proposals and voting instructions are detailed in the Proxy Statement/Circular available on EDGAR and SEDAR+.

Voting matters and shareholder proposals

• Shareholders are asked to approve six director nominees, the proposed auditor, a non-binding advisory vote on executive compensation, and an amendment to the Equity Incentive Plan.

• All proposals have received a favorable recommendation from ISS.

Board of directors and corporate governance

• Six director nominees are up for election at the 2025 Annual General Meeting.